Mark is now leading the effort to design, establish and grow CME Group's Strategic Investment Group (the "SIG"). We will be taking minority stakes in early stage technology companies of long term strategic interest to CME Group and the eco-system within which we operate. During his 13+ years at CME Mark has served in Corporate Finance, M&A, Capital Markets, Corporate Strategy, and Corporate Development roles for the company. From demutualization through the IPO, futures industry consolidation, globalization, expansion into the OTC markets, and optimizing our data-center's Co-location business, he's led several M&A, commercial partnerships, and JV activities involving our Interest Rates, FX, and OTC Clearing business and operating infrastructure. Regular contributions to the development of our corporate strategy and tight coordination with the executive leadership, board members and business line management are keys to Mark's consistent success during the his time at CME Group. Specialties: Mergers & Acquisitions, Commercial Partnerships, Strategic Development.